Here are some drug research updates from my reading-
Trichostatin A may prevent premature labor.
Trichostatin A, a cancer treatment, "may prevent premature labour," according to researchers from Newcastle University publication.
Study indicates basal insulin regimen may be better for some patients with type 2 diabetes.
A publication online in the New England Journal of Medicine indicates that "patients with type 2 diabetes who require insulin on top of oral therapy to control glycated hemoglobin may do better if they start on a basal insulin versus biphasic insulin or prandial insulin."
Researchers examine use of resveratrol to affect type 2 diabetes?
According to a study published online in Journal Endocrinology, reports are that a study in mice population suggests that resveratrol "may help the body fend off type 2 diabetes".
Is Liraglutide a better tool for weight loss than other obesity drugs ?
In a study published online in The Lancet, it has been published that "In the fight against obesity, the investigational diabetes drug liraglutide (Victoza) may be a better tool than some weight loss drugs, even for patients who don't have diabetes, researchers said".
Do incidences of roravirus infection potentially seem to decrease with vaccinations ?
According to data published in the CDC's Morbidity and Mortality Weekly Report ,"Since routine vaccination of infants against rotavirus started in the United States in 2006, there's been a substantial reduction in the number of cases of rotavirus disease in children.
For detailed reading on this topic please visit http://www.pharm-education.com/2009/11/drug-research-and-technology-updates.html
Disclaimer : The above information has been cited from literature in public domain. This is for research purpose/ dissemination of knowledge only and should not be construed as medical advise.